Quantification of Lyssavirus-neutralizing antibodies using vesicular stomatitis virus pseudotype particles

Viruses

Volumn 8, Issue 9, 2016, Pages

  Moeschler, Sarah ^a   Locher, Samira ^a   Conzelmann, Karl Klaus ^b   Krämer, Beate ^c   Zimmer, Gert ^a  

^a INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Biosafety; Immunoglobulin; Luciferase; Pseudotype virus; Rabies virus; Vaccine; Virus neutralization

Indexed keywords

DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RODAPLUTIN; THROMBOSPONDIN; VIRUS ENVELOPE PROTEIN; VIRUS LIKE PARTICLE VACCINE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BIOTINYLATION; CELL CULTURE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IMMUNOFLUORESCENCE; LYSSAVIRUS; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSEUDOTYPING; RECOMBINANT PLASMID; VACCINATION; VERO CELL LINE; VESICULOVIRUS; VIRUS NEUTRALIZATION; WESTERN BLOTTING; ANIMAL; GENETICS; IMMUNOLOGY; PROCEDURES; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; LYSSAVIRUS; MICE; NEUTRALIZATION TESTS; VESICULOVIRUS;

EID: 84989348632     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8090254     Document Type: Article

References (40)

1. Rupprecht, C.E.; Hanlon, C.A.; Hemachudha, T. Rabies re-examined. Lancet Infect. Dis. 2002, 2, 327–343. [CrossRef]
2. Afonso, C.L.; Amarasinghe, G.K.; Banyai, K.; Bao, Y.; Basler, C.F.; Bavari, S.; Bejerman, N.; Blasdell, K.R.; Briand, F.X.; Briese, T. et al. Taxonomy of the order Mononegavirales: Update 2016. Arch. Virol. 2016, 161, 2351–2360. [CrossRef] [PubMed]
3. Badrane, H.; Bahloul, C.; Perrin, P.; Tordo, N. Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. J. Virol. 2001, 75, 3268–3276. [CrossRef] [PubMed]
4. Delmas, O.; Holmes, E.C.; Talbi, C.; Larrous, F.; Dacheux, L.; Bouchier, C.; Bourhy, H. Genomic diversity and evolution of the lyssaviruses. PLoS ONE 2008, 3, e2057. [CrossRef] [PubMed]
5. Kuzmin, I.V.; Novella, I.S.; Dietzgen, R.G.; Padhi, A.; Rupprecht, C.E. The rhabdoviruses: Biodiversity, phylogenetics, and evolution. Infect. Genet. Evol. 2009, 9, 541–553. [CrossRef] [PubMed]
6. Kuzmin, I.V.; Wu, X.; Tordo, N.; Rupprecht, C.E. Complete genomes of Aravan, Khujand, Irkut andWest Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions. Virus Res. 2008, 136, 81–90. [CrossRef] [PubMed]
7. Malerczyk, C.; Freuling, C.; Gniel, D.; Giesen, A.; Selhorst, T.; Muller, T. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species. Hum. Vaccin. Immunother. 2014, 10, 2799–2804. [CrossRef] [PubMed]
8. Fooks, A.R.; Banyard, A.C.; Horton, D.L.; Johnson, N.; McElhinney, L.M.; Jackson, A.C. Current status of rabies and prospects for elimination. Lancet 2014, 384, 1389–1399. [CrossRef]
9. Fooks, A.R.; McElhinney, L.M.; Pounder, D.J.; Finnegan, C.J.; Mansfield, K.; Johnson, N.; Brookes, S.M.; Parsons, G.; White, K.; McIntyre, P.G. et al. Case report: Isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis. J. Med. Virol. 2003, 71, 281–289. [CrossRef] [PubMed]
10. Familusi, J.B.; Osunkoya, B.O.; Moore, D.L.; Kemp, G.E.; Fabiyi, A. A fatal human infection with Mokola virus. Am. J. Trop. Med. Hyg. 1972, 21, 959–963. [PubMed]
11. Francis, J.R.; Nourse, C.; Vaska, V.L.; Calvert, S.; Northill, J.A.; McCall, B.; Mattke, A.C. Australian Bat Lyssavirus in a child: The first reported case. Pediatrics 2014, 133, e1063–e1067. [CrossRef] [PubMed]
12. Paweska, J.T.; Blumberg, L.H.; Liebenberg, C.; Hewlett, R.H.; Grobbelaar, A.A.; Leman, P.A.; Croft, J.E.; Nel, L.H.; Nutt, L.; Swanepoel, R. Fatal human infection with rabies-related Duvenhage virus, South Africa. Emerg. Infect. Dis. 2006, 12, 1965–1967. [CrossRef] [PubMed]
13. Dietzschold, B.; Li, J.; Faber, M.; Schnell, M. Concepts in the pathogenesis of rabies. Future Virol. 2008, 3, 481–490. [CrossRef] [PubMed]
14. Cox, J.H.; Dietzschold, B.; Schneider, L.G. Rabies virus glycoprotein. II. Biological and serological characterization. Infect. Immun. 1977, 16, 754–759. [PubMed]
15. Evans, J.S.; Horton, D.L.; Easton, A.J.; Fooks, A.R.; Banyard, A.C. Rabies virus vaccines: Is there a need for a pan-lyssavirus vaccine? Vaccine 2012, 30, 7447–7454. [CrossRef] [PubMed]
16. Hampson, K.; Coudeville, L.; Lembo, T.; Sambo, M.; Kieffer, A.; Attlan, M.; Barrat, J.; Blanton, J.D.; Briggs, D.J.; Cleaveland, S. et al. Estimating the global burden of endemic canine rabies. PLoS Negl. Trop. Dis. 2015, 9, e0003709.
17. Knobel, D.L.; Cleaveland, S.; Coleman, P.G.; Fevre, E.M.; Meltzer, M.I.; Miranda, M.E.; Shaw, A.; Zinsstag, J.; Meslin, F.X. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organ. 2005, 83, 360–368. [PubMed]
18. Cliquet, F.; Aubert, M.; Sagne, L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J. Immunol. Methods 1998, 212, 79–87. [CrossRef]
19. Smith, J.S.; Yager, P.A.; Baer, G.M. A rapid reproducible test for determining rabies neutralizing antibody. Bull. World Health Organ. 1973, 48, 535–541. [PubMed]
20. Moore, S.M.; Hanlon, C.A. Rabies-specific antibodies: Measuring surrogates of protection against a fatal disease. PLoS Negl. Trop. Dis. 2010, 4, e595. [CrossRef] [PubMed]
21. Wright, E.; McNabb, S.; Goddard, T.; Horton, D.L.; Lembo, T.; Nel, L.H.; Weiss, R.A.; Cleaveland, S.; Fooks, A.R. A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa. Vaccine 2009, 27, 7178–7186. [CrossRef] [PubMed]
22. Hanika, A.; Larisch, B.; Steinmann, E.; Schwegmann-Wessels, C.; Herrler, G.; Zimmer, G. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J. Gen. Virol. 2005, 86, 1455–1465. [CrossRef] [PubMed]
23. Genz, B.; Nolden, T.; Negatsch, A.; Teifke, J.P.; Conzelmann, K.K.; Finke, S.; Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis. Berl. Munchener Tierarztliche Wochenschr. 2012, 125, 219–227.
24. Conzelmann, K.K.; Cox, J.H.; Schneider, L.G.; Thiel, H.J. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. Virology 1990, 175, 485–499. [CrossRef]
25. Marston, D.A.; McElhinney, L.M.; Johnson, N.; Muller, T.; Conzelmann, K.K.; Tordo, N.; Fooks, A.R.; Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 30 non-translated region. J. Gen. Virol. 2007, 88, 1302–1314. [CrossRef] [PubMed]
26. Mebatsion, T.; Schnell, M.J.; Conzelmann, K.K. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles. J. Virol. 1995, 69, 1444–1451. [PubMed]
27. Kalhoro, N.H.; Veits, J.; Rautenschlein, S.; Zimmer, G. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). Vaccine 2009, 27, 1174–1183. [CrossRef] [PubMed]
28. Berger Rentsch, M.; Zimmer, G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS ONE 2011, 6, e25858. [CrossRef] [PubMed]
29. Krämer, B.; Bruckner, L.; Daas, A.; Milne, C. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use. Pharmeuropa Bio Sci. Notes 2010, 2010, 37–55.
30. Krämer, B.; Schildger, H.; Behrensdorf-Nicol, H.A.; Hanschmann, K.M.; Duchow, K. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines. Biologicals 2009, 37, 119–126. [CrossRef] [PubMed]
31. Wulff, N.H.; Tzatzaris, M.; Young, P.J. Monte Carlo simulation of the Spearman-Kaerber TCID50. J. Clin. Bioinform. 2012, 2, 5. [CrossRef] [PubMed]
32. Hoffmann, M.; Wu, Y.J.; Gerber, M.; Berger-Rentsch, M.; Heimrich, B.; Schwemmle, M.; Zimmer, G. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J. Gen. Virol. 2010, 91, 2782–2793. [CrossRef] [PubMed]
33. Johnson, N.; Vos, A.; Freuling, C.; Tordo, N.; Fooks, A.R.; Muller, T. Human rabies due to lyssavirus infection of bat origin. Vet. Microbiol. 2010, 142, 151–159. [CrossRef] [PubMed]
34. Tang, H.B.; Lu, Z.L.; Wei, X.K.; Zhong, Y.Z.; Zhong, T.Z.; Pan, Y.; Luo, Y.; Liao, S.H.; Minamoto, N.; Luo, T.R.; A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assay. J. Virol. Methods 2015, 219, 75–83. [CrossRef] [PubMed]
35. Xue, X.; Zheng, X.; Liang, H.; Feng, N.; Zhao, Y.; Gao, Y.; Wang, H.; Yang, S.; Xia, X. Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test. Viruses 2014, 6, 1578–1589. [CrossRef] [PubMed]
36. Khawplod, P.; Inoue, K.; Shoji, Y.; Wilde, H.; Ubol, S.; Nishizono, A.; Kurane, I.; Morimoto, K. A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein. J. Virol. Methods 2005, 125, 35–40. [CrossRef] [PubMed]
37. Ghanem, A.; Conzelmann, K.K. G gene-deficient single-round rabies viruses for neuronal circuit analysis. Virus Res. 2016, 216, 41–54. [CrossRef] [PubMed]
38. Tani, H.; Morikawa, S.; Matsuura, Y. Development and Applications of VSV Vectors Based on Cell Tropism. Front. Microbiol. 2011, 2, 272. [CrossRef] [PubMed]
39. Kontsekova, E.; Macikova, I.; Novak, M.; Dedek, L.; Vrzal, V.; Kontsek, P. Conformation-dependent accessibility of the linear epitopes located on the rabies virus glycoprotein. Viral Immunol. 1992, 5, 213–220. [CrossRef] [PubMed]
40. Luo, T.R.; Minamoto, N.; Hishida, M.; Yamamoto, K.; Fujise, T.; Hiraga, S.; Ito, N.; Sugiyama, M.; Kinjo, T. Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies. Microbiol. Immunol. 1998, 42, 187–193. [CrossRef] [PubMed]